Abstract:Advanced innovations for combating variants of aggressive cancer and overcoming drug resistance are desired. In cancer treatment, nanoparticles (NPs) have the capacity to specifically and compellingly activate apoptosis of cancer cells. There is also a pressing need to develop innovative anti-cancer therapeutics, and recent research suggests that ZnO nanoparticles hold great potential. The current exploration was designed to fabricate the zinc-nickel nanomaterial (Zn-Ni NPs) and examine its in vitro anticancer effects on lung cancer cell. In ultraviolet–visible spectroscopy (UV-Vis), the bands at the wavelengths of 219, 265, 397, and 458 nm are related to the surface plasmon resonance of the synthetic Zn-Ni NPs. In fourier transform-infrared spectroscopy (FT-IR), the peaks of 449, 618, 659, 662, and 693 can be assigned to Zn-O or Ni-O bonds. The cytotoxicity of the Zn-Ni NPs (1 to 1000 μg/mL) were studied by the MTT assay and the IC50 dose for Zn-Ni NPs were found at 77 μg/mL. The different fluorescent staining assays such as Dichloro-dihydro-fluorescein diacetate, Rhodamine-123, and dual staining were performed to investigate the influence of Zn-Ni NPs on the apoptosis, matrix metalloproteinase status, and reactive oxygen species accumulation in the PC14 cells. The status of inflammatory markers such as IL-6, COX-2, TNF-α, and NF-κB in the PC14 cells were studied. The increased dosage of Zn-Ni NPs were effective repressed the growth of PC14 cells. The PC14 cells treated with Zn-Ni NPs revealed a significantly fewer proliferating cells and more apoptotic cells when compared with control. The Zn-Ni NPs also inhibited the phosphorylation of mTOR and Akt, reducing tumor volume and weight. PC14 cells phosphorylated mTOR, cyclin D1, Akt, and PI3K in response to Zn-Ni NPs. The findings were revealed that the fabricated Zn-Ni NPs considerably increased the ROS accumulation and apoptosis in the PC14 cells. Zn-Ni NPs also enhanced mitochondrial apoptosis through Bcl-2 protein-dependent signaling. In conclusion, Zn-Ni NPs might be promising candidate for lung cancer treatment.

Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture

Antibacterial Peptide Nisin Activates p53 Gene Expression and Triggers Apoptosis in Human Colon Cancer Cells

Stabilization and Anticancer Enhancing Activity of the Peptide Nisin by Cyclodextrin-Based Nanosponges against Colon and Breast Cancer Cells

Nisin and nisin-loaded nanoparticles: a cytotoxicity investigation

The anti-adhesion effect of nisin as a robust lantibiotic on the colorectal cancer cells

SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Marine Antimicrobial Peptide Epinecidin-1 Inhibits Proliferation Induced by Lipoteichoic acid and Causes cell Death in non-small cell lung cancer Cells via Mitochondria Damage

Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and apoptosis

Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells

The Antimicrobial Peptide, Nisin, Synergistically Enhances the Cytotoxic and Apoptotic Effects of Rituximab Treatment on Human Burkitt's Lymphoma Cell Lines

A Novel Anticancer Agent SNG1153 Inhibits Growth of Lung Cancer Stem/progenitor Cells

Daidzein nanosuspension in combination with cisplatin to enhance therapeutic efficacy against A549 non-small lung cancer cells: an in vitro evaluation

SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/mTOR Signaling Pathways

Tizanidine (hydrochloride) Inhibits A549 Lung Cancer Cell Proliferation and Motility Through Regulating Nischarin.

The Cytotoxic Molecule Ansamitocin P-3 Suppresses Cell Proliferation and Tumor Growth in Lung Carcinoma

Induction of Apoptosis and Suppression of Tumor Growth by Nur77-derived Bcl-2 Converting Peptide in Chemoresistant Lung Cancer Cells.

Anticancer activity of zinc-nickel nanocomposite in lung cancer PC14 cells via modulation of apoptosis and P13K/mTOR pathway

Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro

Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer

Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies